Explore more publications!

Hawaiian Business Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaiian Business Post.

Press releases published on April 13, 2026

Boskalis realiseert eerste succesvolle inzet van ROV’s vanuit nieuw Remote Operations Center in Aberdeen
Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield
Epitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer
Boskalis marks first successful ROV deployment from its new Remote Operations Center in Aberdeen
Over a third of Americans would accept twice as many ads for cheaper streaming
Bezeq Group Publishes its 2025 ESG Report
Rising UK Dental Costs and NHS Access Crisis Drive Record Demand for Treatment in Türkiye — DentSpa Leads the Response
Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada
CallTower Expands Channel Leadership with Two Key Director Appointments
FTI Consulting Appoints Benedict Brogan to Strategic Communications Segment
West Red Lake Gold Reports 215.46 g/t Au over 5.35m, 50.34 g/t Au over 4.05m and 61.70 g/t Au over 3m in Austin 904 Complex – Madsen Mine
TaxTec, Proxymity and Label Launch End-to-End MiKaDiv Solution for Withholding Tax Compliance
A Grand Event for the Rubber and Plastics Industry — CYCJET Joins You at Chinaplas 2026
Un gran evento para la industria del caucho y el plástico: CYCJET lo invita a Chinaplas 2026
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene annonce la fin de la randomisation des patients de la partie Phase 2 de l’essai clinique évaluant TG4050 dans le traitement adjuvant des cancers de la tête et du cou
Baker Hughes Announces Sale of Waygate Technologies to Hexagon
Alpha Longevity Management launches U.S. specialty finance strategy for Japanese institutional investors, led by former members of Nikko Asset Management's team
CORRECTION - Israel Tech Week Moves Forward in Miami Amid Ongoing War in Israel
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions